Background: Donor-site morbidity, limited numbers of cells, loss of phenotype during ex vivo expansion, and age-related decline in chondrogenic activity present critical obstacles to the use of autologous chondrocyte implantation for cartilage repair. Chondrocytes from juvenile cadaveric donors may represent an alternative to autologous cells.
Surgeons and scientists have developed a wide variety of approaches to restoring cartilaginous articular surfaces with the intention of relieving pain and improving mobility for people with traumatic or degenerative damage to their synovial joints. One of the most promising methods has been the use of transplanted autologous cells. However, prospective randomized studies comparing cell transplantation with microfracture (penetration of subchondral bone to stimulate cartilage repair) have not shown that cell transplantation produced better results. 19, 20, 35 Potential reasons for the lack of improved results with autologous cell transplantation include the limited number of chondrocytes available for cell therapy and the tendency for chondrocytes to undergo phenotypic change during ex vivo expansion in monolayer culture. 10, 40 Furthermore, there is strong clinical and basic scientific evidence that the chondrogenic potential of chondrocytes and chondrogenic stem cells declines with age. 10, 39, 43 For these reasons, we decided to explore the potential of human juvenile chondrocytes for treatment of articular surface defects. However, an important consideration in utilizing cells derived from allogeneic donor tissue is the potential for immunogenicity. Fresh allogeneic articular cartilage and isolated chondrocytes have been transplanted successfully for 2 to 3 decades with a paucity of adverse events related to rejection. [6] [7] [8] 16, 32, 34 The use of fresh osteochondral allograft tissue to repair contained articular defects has successfully delayed the use of prosthetic implants in young active patients. 6, 7, 37 Although some instances of delayed immunologic rejection associated with transplantation of fresh osteochondral allografts have been reported, it is believed that these reactions are due to incomplete removal of blood/marrow elements from the osseous component and in no way were attributable to cartilage. 36 In this article, we test the hypotheses that juvenile human chondrocytes have significantly greater potential for restoring articular cartilage than chondrocytes from skeletally mature individuals and that juvenile chondrocytes do not stimulate an immunologic response that would compromise their value as a clinically applicable treatment of articular surface defects.
METHODS

Chondrocyte Isolation and Neocartilage Production
Articular cartilage was obtained from deceased human donors following informed consent for use in medical research. Knees en bloc were shipped on wet ice in physiologically buffered solution and stored for no more than 120 hours at 4°C before processing. Only regions of healthy cartilage were used, and those regions of tissue displaying grade 1 or 2 osteoarthritis were avoided in older donors.
The methods for chondrocyte isolation and neocartilage production were essentially as described previously. 1 Briefly, whole knees from 65 different donors were processed aseptically in accordance with current Good Tissue Practices to harvest articular cartilage from the proximal femur and distal tibia. Minced cartilage was disaggregated by sequential enzymatic dissociation in pronase (0.2%), followed by overnight digestion using a mixture of 0.07% collagenase (Worthington, Lakewood, New Jersey) and 0.04% hyaluronidase (Sigma-Aldrich, St Louis, Missouri) in HL-1 chemically defined, serum-free medium (Lonza, Walkersville, Maryland). Of the tissues collected for analysis, 19 were obtained from subjects ranging in age from 13 to 72 years (adult), with the remaining 46 tissues derived from subjects spanning birth to 13 years of age (juvenile). The general distribution of donor tissues was 63% male and 37% female. Neocartilage was produced by seeding 0.5 to 1.0 3 10 6 nonexpanded chondrocytes per cm 2 in HL-1 medium or a proprietary chemically defined medium displaying growth characteristics similar to HL-1. Cultures were supplemented with 50 mg/mL ascorbate after day 3 of culture, with medium exchange occurring every 3 to 4 days. Cultures were maintained at 37°C in a humidified environment consisting of 5% CO 2 . Neocartilage was harvested for characterization and/or used in animal studies between days 44 and 63 of culture.
Population Growth and Differentiation in Culture
Human articular chondrocytes were isolated from 5 juvenile donors (each \1 year old) and 9 adult donors (14, 22, 29, 42, 52, 65, 67, 75 , and 78 years old) by overnight digestion of chopped cartilage in Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, California) containing 0.25 mg/mL collagenase type I and 0.25 mg/mL pronase E (Sigma-Aldrich). The cells were counted, plated in culture flasks, and grown for 5 to 10 days before passaging.
Cells isolated from each cartilage sample were serially passaged in monolayer culture for up to 104 days. The cells were allowed to grow to~80% confluence before trypsinization and replating (1:3 split). Population doublings (PDs) were tracked through time based on cell counts at each passage. The growth rate of each culture was calculated by regression analysis of data collected during the linear phase of the growth (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . The Student t test was used to evaluate the significance of the difference between mean growth rates for juvenile and adult chondrocytes.
At various times during serial monolayer culture (indicated in figures), chondrocytes were suspended at a density of 1 3 10 7 cells/mL in 1% (w:v) low-temperature melting agarose (FMC Bioproducts, Rockland, Maine) in phosphate-buffered saline. The agarose/cell suspensions were cast in 4-mmdiameter cylinders, which were subsequently cut into 3-mmtall disks using a scalpel. Individual disks were cultured in 48-well plates in DMEM/10% FBS supplemented with insulin (0.1 units/mL) and cortisone (0.04 ug/mL) (Sigma-Aldrich). The disks were incubated for 2 weeks at 37°C in an atmosphere consisting of 5% CO 2 , 5% O 2 , and 90% N 2 26 with medium changes every second day. The disks were cryoembedded, sectioned, and mounted on slides, and stained with safranin O, fast green, and Wiegert's hematoxylin after fixation in 10% neutral-buffered formalin (Fisher Scientific, Indianapolis, Indiana). Safranin O-stained sections were scanned at high resolution (103 objective) using a Prior motorized stage (Prior Scientific, Rockland, Massachusetts) and ImagePro (Media Cybernetics, Bethesda, Maryland) software. The total number of nuclei per section and the number of nuclei associated with safranin O staining of the pericellular/territorial matrix were counted using a custom MATLABbased image analysis program (The MathWorks, Natick, Massachusetts) and the percentage of safranin O positive cells was determined. 27 Two sections from each of 3 disk cultures were analyzed for each treatment group. One-way analysis of variance on ranks with Dunn test for multiple comparisons was used to evaluate the significance of differences among the median values (P \ .001).
After growing in monolayer culture through multiple passages up to 35 population doublings, chondrocytes from 3 juvenile donors (\1 year old) and 4 adult donors (22, 43, 53 , and 75 years old) were suspended in agarose (1 3 10 7 cells/mL). After 2 weeks, the agarose cultures were digested in papain and assayed for total sulfated glycosaminoglycans (S-GAGs) using the dimethylmethylene blue assay with chondroitin-6 sulfate (Calbiochem, La Jolla, California) as a standard. 13 Results are reported as S-GAG content per volume of agarose (mg/mm 3 ). The difference in mean S-GAG content between juvenile and adult cultures was evaluated over various intervals of monolayer culture times by t test.
Biochemical Analysis of Neocartilage
Neocartilage cultures prepared from freshly isolated (nonexpanded) juvenile and adult articular chondrocytes were submitted for biochemical analysis to compare the rate of matrix synthesis during in vitro culture. The S-GAG content of individual grafts was determined via colorimetric analysis of papain-digested material as described previously. 13 The DNA content was estimated by fluorometric analysis of the papain digest using Hoechst dye and calf thymus DNA as standard. 21 Samples were assayed in triplicate.
Isolation of RNA and Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Analysis of Gene Expression
Total RNA was extracted from neocartilage by mechanical disruption using the FastPrep Instrument and RNAPro Solution (both from Qbiogene, Inc, Carlsbad, California), followed by RNeasy Mini Kit column purification using the DNase/RNase-free kit from Qiagen, Inc (Valencia, California). The concentration of RNA was measured with an ultraviolet spectrometer, and 260/280 ratios ranged between 1.8 and 2.1. Primers for polymerase chain reaction (PCR) were designed using the Beacon Designer 4 program of the Premier Biosoft International software package (Palo Alto, California) or as supplied by Applied Biosystems (Foster City, California). Polymerase chain reaction primers and TaqMan-labeled probes used for real-time PCR analysis are presented in Table 1 . Genes used for analysis include SOX9, the master regulator of chondrogenesis, 22, 23 as well as genes encoding the cartilage-specific extracellular matrix proteins COL2A1 and COL9A1. The housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was used to normalize data. Real-time PCR reactions were carried out using an iCycler iQ instrument (Bio-Rad, Hercules, California) according to manufacturer's instructions. Reactions were conducted in triplicate to generate a standard curve using RNA-specific primers and TaqMan probes in separate nonmultiplexed reactions. Chondrocyte RNA was introduced into the reaction wells at 8 concentrations: 20 ng, 10 ng, 5 ng, 2 ng, 1 ng, 0.5 ng , 0.2 ng, and 0 ng. The cycling conditions consisted of the following stepwise procedure: cycle 1, 50°C 20 minutes (for reverse transcription [RT]); cycle 2, 95°C for 5 minutes (to destroy RT and denature cDNA:RNA); cycle 3, 95°C for 10 seconds, then 58°C for 1 minute 10 seconds for 50 repeats (for PCR); and cycle 4, hold at 4°C. The calculated efficiency of real-time PCR reactions for each of the collagen genes and GAPDH was greater than 95%, while that of SOX9 was no less than 85%. Values of gene expression were estimated relative to the mean of control values obtained for the reactions spiked with the lowest amounts of RNA. From these relative gene expression values, a mean relative expression value was calculated. One-way analysis of variance was used to determine the statistical significance of age-related differences in gene expression of chondrocytes obtained from juvenile and adult articular cartilage. The criterion for significance was P \ .05.
Histologic Characterization and Immunostaining of Neocartilage
Neocartilage specimens were fixed for 24 hours in 10% neutral buffered formalin, rinsed 3 times in phosphate-buffered In Vitro Assessment of Lymphocyte Priming to Transplanted Neocartilage
A study evaluating potential immune responses to implanted neocartilage was performed in adult Spanish goats (n 5 3), with an end point at 12 weeks postimplantation. A full-thickness chondral defect, approximately 6 mm in diameter, was created in the medial femoral condyle using a stainless steel coring device and a curet via an open parapatellar approach. Human neocartilage xenografts (n 5 3; day 63 of culture in HL-1 complete serum-free medium using P1 cells), derived from a single juvenile donor (male, 7 weeks of age), were affixed to subchondral bone using commercial fibrin sealant in 3 separate animals and the stifle joints were closed in layers. Pre-and posttransplant blood was collected from goats receiving neocartilage xenografts. Lymphocytes were isolated from peripheral blood using histopaque gradients, washed, and cryopreserved. Chondrocytes used to generate the neocartilage for the animal study were cryopreserved (P1 cells, 3.8 PDs) for subsequent use in the mixed lymphocyte/chondrocyte reaction (MLCR). Co-cultures of human chondrocytes and goat lymphocytes were established within 3 months after lymphocyte cryopreservation. The number of viable lymphocytes used as responder cells in MLCR assays was held constant at 2 3 10 5 per well, and the stimulatory capacity of irradiated chondrocytes was tested at 1 3 10 5 cells per well. On day 5 of culture, assay plates were pulsed with 1 mCi 3 H-thymidine during the final 18 hours of culture. Cells were then harvested, and radiolabel uptake was assessed by liquid scintillation counting. Raw data were reported as the mean counts per minute 6 standard error of the mean (SEM) of quadruplicate samples. To simplify interpretation, these data were converted to stimulatory index (ie, fold-increase over background counts generated by responders alone). Human peripheral blood leukocytes (PBLs) derived from healthy donors were used in the MLCR for comparative purposes to demonstrate that antigen presenting cells of human origin could drive proliferation of goat lymphocytes.
RESULTS
Juvenile Articular Cartilage Chondrocytes Demonstrate Superior Biologic Activity as Compared With Adult Chondrocytes
Early in the development of neocartilage, it was observed that traditional culture methods, in particular supplementation of basal medium with 10% serum, markedly reduced the ability of cultured human articular chondrocytes to deposit an insoluble hyaline extracellular matrix in vitro. 1 Consequently, a variety of novel-defined serum-free media formulations were developed and tested to optimize matrix Figure 1 . Chondrocytes from juvenile human articular cartilage (\10 years) show significantly greater matrix synthesis potential than chondrocytes isolated from skeletally mature individuals. Neocartilage was grown under defined serumfree conditions as described previously. 28 Matrix proteoglycan content of newly synthesized neocartilage was measured colorimetrically using dimethylmethylene blue after papain digestion of day 44 to 60 grafts. Data are expressed as the average daily amount of proteoglycan deposited in the tissue matrix after normalization to DNA content. The rate of total sulfated glycosaminoglycan (S-GAG) synthesis for juvenile chondrocytes was more than 100-fold greater than that of adult chondrocytes. For reasons that remain unclear, this potent biologic activity appears to decrease with age and may be lost at pubescence.
Vol. 38, No. 7, 2010 Juvenile Chondrocytes and Articular Cartilage Restoration 1327 production in the absence of exogenous growth factors by chondrocytes derived from articular cartilage. Functional studies were performed in vitro to measure de novo synthesis of cartilage matrix from chondrocytes that had been isolated from more than 65 cartilage donors of increasing age. Figure 1 illustrates the effect of donor age on chondrocyte matrix production during static culture in vitro. When maintained under defined conditions, chondrocytes derived from juvenile articular cartilage were found to be 2 orders of magnitude more efficient in producing laboratory-grown neocartilage than adult articular chondrocytes. An exponential decline in chondrocyte matrix synthesis, as measured by S-GAG content, was observed to occur at pubescence and showed no gender dependence. These results suggested that there may be a fundamental difference in the biologic activity of juvenile and adult articular chondrocytes that is reflected at the molecular level. Subsequent work aimed at understanding potential mechanisms regulating the age-dependent loss of chondrocyte matrix synthesis suggested that a decline in collagen gene expression may limit the amount of tissue ultimately formed by adult articular chondrocytes during in vitro culture. Cartilage is composed of a collagen framework into which aggregates of aggrecan are entrapped. Because type IX and type II collagen interact to form fibrilar crosslinks to which newly synthesized proteoglycan macromolecules are bound, we examined whether loss of matrix production by adult chondrocytes may be associated with direct changes in the level of gene expression for type II and/or type IX collagen.
Real-time PCR analysis revealed marked differences in mRNA level for each of these genes in freshly isolated chondrocytes from adult as compared with juvenile human articular cartilage. The relative level of gene expression for collagen types II and IX were reduced by a factor of 100fold and 700-fold, respectively, in adult relative to juvenile donor tissue ( Figure 2 ). Assuming that mRNA levels measured by real-time PCR reflect the amount of protein synthesized in vitro, it is plausible that a reduction in collagen gene expression directly affects the ability of adult articular chondrocytes to form neocartilage tissue in vitro and to initiate repair in vivo. Surprisingly, the mRNA levels of SOX9, considered by many to be the master regulatory gene critical for maintenance of chondrocyte phenotype, 22, 23 were nearly 2-fold higher in adult chondrocytes than juvenile chondrocytes. The ratio of COL2A1/SOX9 was reduced by a factor of 200-fold in adult chondrocytes as compared juvenile articular chondrocytes, supporting the conclusion that SOX9 mRNA levels do not control type II collagen expression in juvenile and adult articular chondrocytes. 3 
Juvenile Articular Cartilage Chondrocytes Generate Hyaline Articular Cartilage In Vitro
Neocartilage has been characterized previously and, based on its collagen and glycoprotein content, closely resembles juvenile hyaline cartilage. 1 To confirm the hyaline phenotype of neocartilage in the present study, collagen types II, VI, and IX were identified by immunohistochemical localization (Figures 3A, 3C, and 3E ), using native articular cartilage derived from a 10-year-old male donor as a positive control (Figures 3B, 3D, and 3F ). As expected, the extracellular matrix of neocartilage showed rather uniform staining for both type II collagen ( Figure 3A ) and type Figure 2 . Real-time polymerase chain reaction analysis demonstrates 100-fold and 700-fold greater amounts of mRNA for type II (A) and type IX (B) collagen, respectively, in freshly isolated chondrocytes derived from juvenile versus adult human articular cartilage. Gene expression profile analysis of chondrocyte-specific genes was performed as described in the Methods section using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for data normalization. A marked reduction in collagen gene expression of adult chondrocytes was observed independent of SOX9 expression (C), the master chondrogenic transcription factor of cartilage, which was expressed at approximately the same order of magnitude in juvenile and adult chondrocytes (approximately 83% greater in adult). The ratio of COL2A1/SOX9 mRNA (D) was reduced 200-fold in adult chondrocytes as compared with juvenile articular chondrocytes (n 5 5 for juvenile chondrocytes, mean age 5 5.6 months, range 5 1 day-19 months; n 5 3 for adult chondrocytes, mean age 5 50.7 years, range 5 35-70 years].
IX collagen ( Figure 3C ). Type VI collagen staining of neocartilage ( Figure 3E ) appeared to localize to the pericellular matrix surrounding chondrocytes, confirming our earlier observation by transmission electron microscopy of beaded filaments in direct association with the chondrocyte plasma membrane of neocartilage. 1
Growth and Differentiation of Juvenile and Adult Chondrocytes
Growth rates were calculated for chondrocyte cultures derived from donors of various ages (\1 year old to 78 years old, mean 5 34 years). Linear regression analysis revealed a weak correlation between age and PDs (r 5 0.58) (Figure 4) . However, the mean growth rate for juvenile cells was significantly greater than for adult cells (P 5 .002).
Extracellular Matrix Production
Safranin O staining of agarose disk cultures after 2 weeks of incubation revealed age-and passage-related differences in extracellular matrix accumulation ( Figures 5A-5D ). Quantitative image analysis showed that after 2 passages in monolayer culture, nearly all chondrocytes (89% 6 6%) from juvenile cartilage samples were positive ( Figure  5E ). After 3 passages, there was statistically insignificant reduction in the percentage of positive cells in cultures from juvenile cartilage (74% 6 6%). In second-passaged cultures from adult cartilage, there were significantly fewer positively stained chondrocytes (47% 6 7%) than in cultures from juvenile cartilage. By the third passage, the number of positive cells in cultures from adult cartilage declined to 9% 6 4%. This was significantly lower than in juvenile cells at the same passage and a significant reduction relative to adult cells at passage 2. Sulfated glycosaminoglycan assays showed growth-dependent declines in proteoglycan content in both juvenile and adult cells (Figure 6) . However, the decline was more dramatic in adult cell cultures than in juvenile cell cultures, which produced significantly more proteoglycan at 5 to 15 PDs (P 5 .030), at 15 to 25 PDs (P 5 .008).
Allogeneic Juvenile Chondrocytes and Cell-Mediated Immunogenicity
Because the technology used to generate neocartilage is amenable to large-scale manufacturing and allows treatment of multiple subjects from a single allogeneic donor, it is important to understand the immunologic consequences of transplantation of allogeneic neocartilage. A potential technical hurdle that would limit the use of allogeneic neocartilage for tissue repair is the possibility that chondrocytes are immunogenic and may stimulate an anti-graft immune rejection response. Although the immunology of cartilage in general, and chondrocytes in particular, remains incompletely understood, earlier studies utilizing the MLCR suggested that juvenile chondrocytes display unique immunologic properties that may minimize graft rejection. 2 Chondrocytes did not stimulate T-cell proliferative responses in vitro, and they suppressed, in a contact-dependent fashion, the proliferation of activated T cells.
To address the question in goats of whether host subjects become sensitized to human neocartilage-derived chondrocytes after neocartilage transplantation, the proliferative activity of host lymphocytes was measured in vitro using goat PBLs as responder cells both before transplantation and at 12 weeks after neocartilage transplantation. As described in the Methods section, the study design utilized xenografts of human origin that were affixed to the central aspect of the medial femoral condyle of adult goats. Incubation of irradiated human chondrocytes either with pre-or posttransplant goat PBLs did not result in PBL proliferation, suggesting that T-lymphocyte priming to human chondrocytes did not occur after neocartilage transplantation (Figure 7) . These findings support previous histologic data demonstrating the absence of lymphocytic infiltration into neocartilage-treated defects as well as the surrounding synovial tissue. 1, 15, 24 Human PBLs were used as a positive control stimulator cell population. In contrast to human chondrocytes, co-incubation of irradiated human PBLs with goat PBLs resulted in lymphocyte proliferative responses ranging from 7-to 65-fold above background, indicating that goat T cells can be stimulated by xenogenic antigens expressed on human cells. These data further support the concept that transplantation of human neocartilage into goats did not result in the priming of host T cells and suggest that transplanted neocartilage will not elicit T cell-mediated host anti-graft immune rejection responses.
DISCUSSION
In terms of extracellular matrix production, we found that juvenile-derived chondrocytes significantly outperformed chondrocytes from adult donors in 2 very different culture systems (serum vs serum-free media, agarose vs scaffoldfree). Strong matrix accumulation (.30 mg/mm 3 S-GAG) was still seen in agarose cultures of juvenile-derived cells These results provide evidence of the strongly enhanced chondrogenic potential of juvenile chondrocytes versus adult chondrocytes. Moreover, data from our lymphocyte proliferation assays suggest that juvenile chondrocytes may not be immunogenic in adult hosts, supporting the possibility that such cells may be used as allografts for cartilage regeneration in vivo.
The treatment of full-thickness articular cartilage defects in the knee remains a significant clinical challenge. Unlike vascularized tissues, adult articular cartilage displays a limited capacity for repair and, once damaged, does not heal. 17 Furthermore, if the subchondral bone is also damaged, a fibrous repair response emanating from the marrow space results in the formation of a fibrocartilaginous tissue incapable of duplicating the biochemical composition and functional properties of native hyaline cartilage. 9, 20, 33 Consequently, chondral and osteochondral lesions arising from acute traumatic injury may progress to premature osteoarthritis, particularly in young active subjects. 25 Cell-based orthobiologic strategies aimed at replacing cartilage damaged by acute injury or repeated minor trauma may delay the onset and progression of degenerative joint disease, thereby reducing the dependence on arthroplastic reconstruction and increasing patient quality of life. The development of novel cell-based therapeutic approaches to cartilage repair requires the identification and utilization of cells that can be manipulated ex vivo to produce a tissue displaying hyaline characteristics. The resulting implant must retain sufficient synthetic activity to integrate with surrounding host tissues and remodel to form a functional replacement tissue.
Unlike adult osteochondral grafts (of either autologous or allogeneic origin), grafts prepared from juvenile joints were reported to show complete integration of cartilage at the graft/host junction in adult animals. 37 Comparable findings have been reported in animals with implantation of cell-based constructs prepared using juvenile articular chondrocytes. 4, 30, 31 In fact, Namba et al 29 demonstrated that 100-mm-deep lacerations created in the superficial surface of fetal articular cartilage undergo spontaneous healing within 28 days after injury, suggesting that juvenile chondrocytes may retain sufficient biologic activity to stimulate integrative repair without scar formation.
To overcome the limitations of autologous chondrocyte implantation, currently the only approved cell-based therapy for articular cartilage repair, 41 it may be necessary to harness the biologic activity of juvenile articular chondrocytes. In recent years, an improved understanding of chondrocyte biology has led to the development of novel in vitro techniques resulting in reproducible manufacturing of neocartilage allografts, 3-dimensional cartilaginous tissues produced independently of bioresorbable scaffolds. 1 As . Mixed lymphocyte/chondrocyte reaction (MLCR) culture analysis for potential priming of host lymphocytes after human neocartilage transplantation demonstrates a lack of sensitization 12 weeks after implantation. Cellbased immunity against the implanted grafts was screened 12 weeks after implantation using the MLCR. Goat lymphocytes collected before and after implantation were used as responder cells for analysis as described in the Methods section. No evidence of lymphocyte priming by the implanted neocartilage-derived chondrocytes was observed, despite the fact that goat lymphocytes displayed potent proliferative responses to human peripheral blood leukocytes (PBLs) used as the positive control (ranging from 7-fold to 65-fold above background).
shown previously 1 and in the current study, the biochemical composition and morphologic features of tissue-engineered neocartilage are consistent with those of hyaline articular cartilage derived from juvenile subjects. Comparative studies evaluating the biosynthetic capacity of freshly isolated juvenile and adult chondrocytes revealed that cells derived from juvenile donor tissue were 100-fold more active than their adult counterparts at producing cartilaginous tissue in vitro.
To understand at the molecular level why adult and juvenile human chondrocytes display marked differences in their ability to produce neocartilage tissue in vitro, quantitative TaqMan analysis of a select group of anabolic gene products characteristic of the chondrocyte phenotype was performed. This analysis revealed an inverse correlation between chondrocyte age and mRNA levels for collagen 2A1 and 9A1 of cells freshly isolated from human articular cartilage. While the levels of mRNA for collagen 2A1 were reduced in adult chondrocytes by a factor of 100 as compared to juvenile chondrocytes, those of type 9A1 were reduced by 700-fold. The potential significance of this observation is underscored by the following rationale. First, collagen comprises two-thirds of the dry weight of articular cartilage, forming a meshwork into which proteoglycan aggregates are entrapped. 12 Thus, the observed reduction in collagen mRNA expression appears to correlate with the in vitro loss of chondrocyte function for cells harvested from adult articular cartilage. Secondarily, experimental evidence strongly suggests that type IX collagen plays an important role in the assembly and maintenance of normal cartilage structure. Transgenic mice with a truncated form 28 or complete deletion of the a1 (IX) chain 14 are predisposed to microscopic degenerative changes in cartilage structure suggestive of osteoarthritis. As a prototypical FACIT (fibril-associated collagens with interrupted triple helices) collagen, type IX collagen is reported to form cross links both with type II collagen and with itself at a minimum of 6 different sites. 11 Finally, it has been shown that type IX collagen interacts with other extracellular matrix proteins such as cartilage oligomeric matrix protein and matrilin-3 and that this interaction is critical to cartilage matrix assembly. 5, 38 In light of the observed 100-to 700-fold reduction in collagen gene expression, our findings provide new evidence that adult chondrocytes may not provide an ideal source of chondrogenic cells capable of restoring cartilage damage arising from traumatic injury or disease. Surprisingly, Sox9 gene expression by chondrocytes from adult articular cartilage was nearly 2-fold greater than that measured for juvenile cartilage. Although this transcription factor is believed to control chondrocyte matrix synthesis, the reduced level measured for juvenile human articular cartilage did not appear to be predictive of enhanced chondrogenic potential. We speculate that this observation may be attributed to cells undergoing mitogenesis as these tissues were harvested from individuals younger than 2 years of age.
To the best of our knowledge, this is the first report correlating marked differences in chondrocyte functional activity to gene expression for human articular chondrocytes harvested from juvenile and adult articular cartilage. This age-dependent decrease in chondrocyte type IX collagen mRNA levels is reminiscent of the changes in gene expression reported to occur following serial monolayer culture of bovine chondrocytes and may be a harbinger of the differentiation state of articular chondrocytes. 42 From the data presented, it is clear that juvenile articular chondrocytes offer a significant biologic advantage over cell therapies comprising adult articular chondrocytes. Furthermore, use of juvenile articular chondrocytes derived from allogeneic cadavers would eliminate donor-site morbidity and the requirement for 2 surgical procedures associated with therapeutic application of autologous chondrocyte implantation.
To address the immunologic consequence of transplanting nonautologous (human) chondrocytes on the host immune response, in vitro assessment of lymphocyte proliferation was assessed using lymphocytes recovered from goats. Our findings indicate that, unlike professional antigen-presenting cells, chondrocytes do not stimulate proliferation of allogeneic or xenogeneic lymphocytes. 2 These observations are consistent with those of Jobanputra et al, 18 who demonstrated that chondrocytes fail to evoke lymphocyte alloproliferation even after induction of class II antigens with cytokine treatment.
In conclusion, allogeneic chondrocytes derived from human juvenile articular cartilage may represent an improved source of cells for cartilage repair. These cells are amenable to large-scale manufacturing and display an inherent enhanced ability to synthesize cartilage matrix when compared with adult chondrocytes. Finally, the in vivo immunogenicity studies described here suggest that allogeneic juvenile chondrocytes, when transplanted with neocartilage, will not promote graft rejection immune responses in unrelated recipients.
